medigraphic.com
ISSN 2221-2434 (Electronic)

2015, Number 2

<< Back

Finlay 2015; 5 (2)

Effects of the use of glucocorticoids during pregnancy. A case report

Machado RD

Language: Spanish
References: 21
Page: 139-144
PDF size: 162.18 Kb.


ABSTRACT

The use of anti-inflammatory glucocorticoids may be necessary during pregnancy to treat some maternal conditions. Its effects in pregnant women are virtually the same as those described in the general adult population. Avascular necrosis is the death of bone tissue due to the interruption of the blood supply, and is mainly associated with the use of high-dose corticosteroids for long periods. We present the case of a 21-year-old patient at 34 weeks’ gestation admitted to the Intensive Care Unit of the Enrique Cabrera Hospital because of decompensated hypertension, obesity and congenital adrenal hyperplasia treated with suppressive doses of steroids. Subsequently, she was diagnosed with an avascular necrosis of both femoral heads. Iatrogenic Cushing’s syndrome resulting from all these factors was found. The newborn developed a seborrheic dermatitis of the scalp. The purpose of this presentation is to describe the side effects of the chronic use of glucocorticoids in pregnant women.


REFERENCES

  1. de Cross GA. Córticoterapia durante el embarazo. RAEM. 2006 ; 43 Suppl 1: S1-2.

  2. Janssen NM, Genta MS. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med. 2000 ; 160 (5): 610-9.

  3. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. 5th. ed. Philadelphia: Williams and Wilkins; 1998.

  4. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. 6th. ed. Philadelphia: Williams and Wilkins; 2002.

  5. Halperin I, Obiols G, Soto A, Torres E, Tortosa F, Catalá M, et al. Guía clínica de las modificaciones hipotalamohipofisarias en el embarazo y en el período posparto. Endocrinología y Nutrición. 2013 ; 55 (1): 29-43.

  6. Aguilera C, Agustí A. ¿Es segura la administración de glucocorticoides durante el embarazo?. Med Clin. 2003 ; 120 (10): 395-6.

  7. Fraser FC, Sajoo A. Teratogenic potential of corticosteroids in humans. Teratology. 1995 ; 51 (1): 45-6.

  8. Rodríguez E, Martínez ML. Corticosteroids during pregnancy and oral clefts: a case-control study. Teratology. 1998 ; 58 (1): 2-5.

  9. Gat J, Cavallascu JA. Necrosis avascular bilateral del escafoides (enfermedad de Preiser) una causa infrecuente de dolor de muñeca. Reumatol Clin. 2014 ; 10 (6): 131-92.

  10. Saavedra MA, Barrera A, Cabral AR, Jara LJ, Arce AC, Álvarez J, et al. Guías de práctica clínica para la atención del embarazo en mujeres con enfermedades reumáticas autoinmunes del colegio Mexicano de Reumatología Parte II. Reumatol Clin. 2015 ; 11 (1): 1-20.

  11. Cheong JL, Burnett AC, Lee KJ, Roberts G, Thompson DK, Wood SJ, et al. Association between postnatal dexamethasone for treatment of bronchopulmonary dysplasia and brain volumes of adolescence in infants born very preterm. J Pediatr. 2014 ; 164 (4): 737-43.

  12. Tam EW, Chau V, Ferriero DM, Barkovich AJ, Poskitt KJ, Studholme C, et al. Preterm cerebellar growth impairment after postnatal exposure to glucocorticoid. Sci Transl Med. 2011 ; 3 (105): 105.

  13. Wilber AA, Lin GL, Wellman CL. Glucocorticoid receptor blockade in the posterior interpositus nucleus reverses maternal separation-induced deficits in adult eyeblink conditioning. Neurobiol Learn Mem. 2010 ; 94 (2): 263-8.

  14. Maloney SE, Noguchi KK, Wozniak DF, Fowler SC, Farber NB. Long-term effects of multiple glucocorticoid exposures in Neonatal Mice. Behav Sci(Basel). 2011 ; 1 (1): 4-30.

  15. Tam EW. Potential mechanism of cerebellar hypoplasia in prematurity. Neuroradiology. 2013 ; 55 Suppl 2: S41-6.

  16. Ching Ch, Chia WL, Fenella W, Gudula K. Seguridad de los esteroides tópicos en el embarazo. Cochrane. 2010 ; 3 (1): 1-5.

  17. Serra HA, Roganovich JM, Rizzo LF. Glucocorticoides: paradigma de medicina traslacional. De lo molecular al uso clínico. Medicina. 2012 ; 72 (2): 5-10.

  18. Kemp S, Berger J, Aubourg P. X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects. Biochim Biophys Acta. 2012 ; 1822 (9): 1465-74.

  19. Rica I, Grau G, Vela A. Insuficiencia Suprarrenal. Protoc Diagn Ter Pediatr. 2011 ; 1 (1): 166-76.

  20. Aguirre MA, Luna M, Reyes Y, Gómez R, Benítez I. Diagnóstico y manejo de la insuficiencia adrenal. Rev Venez Endocrinol Metab. 2013 ; 11 (3): 5-9.

  21. Roche M, Pérez AF, García MA, Martínez I. Patología médica y embarazo: Trastornos respiratorios, urológicos, infecciosos y endocrinológicos. Anales Sis San Navarra [revista en Internet]. 2009 [ cited 11 Jun 2015 ] ; 32 Suppl 1: [aprox. 10p]. Available from: http://scielo.isciii.es/scielo.php?script=sci_arttext &pid=S1137-66272009000200012&lng=es.




2020     |     www.medigraphic.com